Paediatric hip--ultrasound screening for developmental dysplasia of the hip: a review

P Tomà1, M Valle, U Rossi

  • 1Radiology/Orthopaedy II. G. Gaslini Institute, Largo Gaslini 5, I-16148 Genoa, Italy. paolotoma@ospedale-gaslini.ge.it

Insights

Routine ultrasound screening for developmental dysplasia of the hip (DDH) in newborns is effective. Optimized screening protocols can minimize overtreatment and resource waste while ensuring infant hip health.

Area of Science:

  • Pediatrics
  • Radiology
  • Orthopedics

Background:

  • Developmental dysplasia of the hip (DDH) is a condition requiring early detection.
  • Ultrasound (US) screening is a common method for identifying DDH in infants.
  • Concerns exist regarding the accuracy and potential overtreatment associated with US screening for DDH.

Purpose of the Study:

  • To evaluate the effectiveness of ultrasound screening for developmental dysplasia of the hip (DDH).
  • To determine the clinical significance of sonographic findings in neonatal hip screening.
  • To assess the impact of overtreatment on resources and patient morbidity.

Main Methods:

  • Literature review from January 1996 to December 2000.
  • Analysis of 4 years of hip ultrasound screening data from 11,326 infants (aged 3 days to 4 months).
  • Tracking of abnormal sonographic findings, treatment rates, and complications such as avascular necrosis.

Main Results:

  • Abnormal sonographic hip findings were present in 4.7% of infants.
  • 3.36% of infants had type IIa hip findings, with 65% normalizing on follow-up.
  • Treatment was initiated in 2.5% of infants, with a 1.06% rate of avascular necrosis.

Conclusions:

  • Routine generalized ultrasound screening of neonatal hips is supported.
  • Optimizing screening approaches can limit false positives and reduce overtreatment.
  • Effective screening balances early detection with minimizing unnecessary interventions and associated risks.